Dr. Collins will discuss anti-inflammatory & anti-aging applications of systemic enzyme therapy, including Wobenzym(R) PS
QUEBEC CITY, Dec. 10 /CNW Telbec/ - Atrium Innovations Inc. (TSX: ATB), a leading developer, manufacturer and marketer of science-based and professionally supported products for the Health and Nutrition industry, today announced that Dr. Joseph J. Collins, RN, ND, will make a presentation at the Annual Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies in Las Vegas, Nevada, USA. Dr. Collin's presentation, "Systemic Enzyme Therapy: Anti-Inflammatory & Anti-Aging Applications" will be held at 9:30 a.m. on Saturday, December 12, 2009, in the Bayside A room of the Mandalay Bay Resort and Convention Center.
Dr. Collins' presentation will provide a detailed discussion of the anti-inflammatory mechanisms and clinical applications of oral proteolytic enzymes. He will highlight the research behind the Wobenzym(R) family of products, the leading whole-body systemic enzyme, which has been clinically proven to support immune function, joint, muscle and tendon health. Wobenzym(R) PS is the leading German formulation of bromelain, trypsin, and rutin, is the subject of over 60 human clinical trials, involving over 7000 subjects, and is available in the U.S. through licensed health care professionals.
About Dr. Joseph J. Collins, RN, ND
Dr. Joseph Collins is a Registered Nurse and Naturopathic Physician. He earned his degree in naturopathic medicine at the National College of Naturopathic Medicine, Portland, OR, and is a licensed practitioner in the state of Washington. Dr. Collins' private practice is focused on integrative and functional endocrinology, and cellular signaling. He has developed expertise on the interpretation of the opposing, antagonistic, or synergistic relationships between the biomarkers that define the aging process. He has served as a consultant to numerous diagnostic laboratories, nutraceutical companies, and pharmacies, and is an educator and consultant to physicians, pharmacists, and consumer groups on diagnostic and therapeutic applications in functional medicine. In addition to his expertise in endocrinology, Dr. Collins is a certified leader in the Chronic Disease Self-Management Program developed at Stanford School of Medicine, and he is an expert on systemic enzyme therapy for the management of acute and chronic inflammatory conditions.
About Wobenzym(R) PS
Backed by decades of clinical research, Wobenzym(R) PS is a clinically proven combination of specific enzymes to support immune function, joint, and muscle and tendon health. Wobenzym(R) PS and the Wobenzym(R) family of products are scientifically proven effective and safe, and continue to lead the industry as the world's #1 whole-body systemic enzyme formulations. Wobenzym(R) PS is available through health care professionals and may be a useful dietary supplement for individuals wishing to support healthy joints, immune, and circulatory functions.
Atrium Innovations Inc. is a globally recognized leader in the innovation, formulation, production and commercialization of science-based and professionally endorsed products for the Health & Nutrition industry. The Company focuses primarily on growing segments of the health and nutrition markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of finished products through its highly specialized sales and marketing network in more than 35 countries, primarily in North America and Europe. Atrium has approximately 900 employees and operates seven manufacturing facilities. Additional information about Atrium is available on its website at www.atrium-innovations.com.
SOURCE Atrium Innovations Inc.
For further information: For further information: Investor Relations: Mario Paradis, Vice President and Chief Financial Officer, (418) 652-1116, email@example.com